Blue Bell Private Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-759
Closed -$1K 735
2022
Q2
$1K Hold
759
﹤0.01% 672
2022
Q1
$2K Sell
759
-600
-44% -$1.58K ﹤0.01% 657
2021
Q4
$5K Buy
+1,359
New +$5K ﹤0.01% 517